Statement Of Cash Flows

Astellas Pharma Inc. - Filing #7258550

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
362,170,000,000 JPY
333,090,000,000 JPY
Cash flows from operating activities
Cash flows from operating activities

Talk to a Data Expert

Have a question? We'll get back to you promptly.